1[1]Tan EM,Cohen AS,Fries JF,et al.The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1982,25( 11 ) :1217
2[2]Liang M H,Socher S A,larson M G,et al.Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.Arthritis Rheum,1989,32 ( 1 ) :107
3[3]Atsumi T,Khamashta MA,Andujar C,et al.Elevated plasma lipoprotein (a) level on its association with impaired fibrinolysis in patients with antiphospholipid syndrome.J Rheumatol,1998,25( 1 ) :69
6Bizzaro N, Tomutti E, Villalta D, et al. Prevalence and cliniclal correlation of anti-phospholipid binding protein antibodies in anti- cardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages [ J ]. Arch Pathol Lab Med,2005,129(2) :61 -68.
7Pengo V, Biasiolo A, Pegoraro C, et al. Antibody profiles for the diagnosis of antiphospholipid syndrome [ J ]. Thromb Haemost,2005, 93(6) :1147 - 1152.
8Antolin J, Almeida D, Amerigo M J, et al. Anti-beta2-glycoprotein-I antibodies and systemic lupus erythematosus[ J]. Med Clin,2002, 119(4) :331 -332.
9Ma K, Simantov R, Zhang JC, et al. High affinity binding of beta 2- glycoprotein 1 to human endothelial ceils is mediated by annexin Ⅱ. [J].J Biol Chem,2000,275 (9) :15541 -15548.
